Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Gentian Diagnostics ASA Director's Dealing 2025

Mar 3, 2025

3604_dirs_2025-03-03_97cd08bb-4a7a-43f7-b417-0274142bd228.html

Director's Dealing

Open in viewer

Opens in your device viewer

Mandatory notification of trade

Mandatory notification of trade

Moss, 3 March 2025

Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction has been completed by a close associate of a primary insider in Gentian:

Holta Invest AS, a close associate of Espen Tidemann Jørgensen, a board member and primary insider in Gentian, has sold 1,228,502 shares in Gentian at NOK 46.50 per share.

PCA notification pursuant to the EU Market Abuse Regulation Article 19 is attached.

This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act, EU Market Abuse Regulation Article 19 and Euronext Oslo Rule Book II.

For further information, please contact: Njaal Kind, Group CFO, [email protected], +47 91 90 65 25